Inclusion Body Myositis Market Growth Driven by Aging Population

добавлена новая статья Другое

2025-05-27 11:37:08 -

Inclusion body myositis (IBM) is a rare, progressive inflammatory muscle disorder characterized by muscle weakness and degeneration. Current treatment products include immunoglobulin therapies, corticosteroids, and emerging monoclonal antibodies, each designed to modulate the immune response and slow disease progression. Advantages of these therapies lie in targeted immunomodulation, improved...

0 Комментарии 0 Поделились 407 Просмотры 0 предпросмотр